新型冠状病毒疫苗接种后新发与复发性眼部炎症的异质性表现:多中心报告与文献综述
这项回顾性多中心队列研究纳入2020至2021年间在新型冠状病毒疫苗接种后42天内出现眼部炎症的患者,其中无葡萄膜炎病史者(新发)22例36眼,有葡萄膜炎病史者(复发)17例19眼。前葡萄膜炎最常见,多数患者仅需观察、局部或全身糖皮质激素治疗即可达到炎症静止,整体发生率低;HLA-B27阳性率高于基线人群报道水平。
要点
- 接种后42天内出现眼部炎症者共39例55眼,新发22例36眼,复发17例19眼。
- 前葡萄膜炎最常见,多数仅需观察、局部或全身糖皮质激素治疗即达静止。
- 研究期间新发葡萄膜炎转诊中12.3%与新冠疫苗接种相关,静止期葡萄膜炎患者接种后仅0.85%出现复发。
核心结论
- 多数被认为继发于新型冠状病毒疫苗接种的炎症经观察或糖皮质激素治疗达到静止,整体发生率低。
- 前葡萄膜炎是最常见的表现。
- HLA-B27阳性率高于基线人群报道水平。
研究设计与样本
- 回顾性、多中心队列研究,于2020年至2021年间开展。
- 纳入无葡萄膜炎病史(新发)或已知葡萄膜炎病史(复发)且在新型冠状病毒疫苗接种后42天内出现眼部炎症的患者。
- 评估葡萄膜炎特征、治疗方式与临床结局。
主要发现
- 共识别39例55眼与疫苗接种时间相关的眼部炎症,其中新发22例36眼,复发17例19眼。
- 前葡萄膜炎最常见。
- 新发患者中HLA-B27阳性6例(27.2%),复发患者中5例(29.4%)。
- 多数患者仅需观察、局部或全身糖皮质激素治疗。
- 研究期间新发葡萄膜炎转诊中12.3%与新型冠状病毒疫苗接种相关;有静止期葡萄膜炎病史者中仅0.85%在接种后出现复发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the patterns of ocular inflammation after coronavirus disease 2019 vaccination, assess underlying commonalities, and understand outcomes. METHODS: Retrospective, multicenter cohort study, conducted between 2020 and 2021. Patients with no previous uveitis history ( de novo ) or a known uveitis history (recurrent) who developed ocular inflammation within 42 days of coronavirus disease 2019 vaccination were identified. Characteristics of the uveitis, treatment approaches, and clinical outcomes were assessed. RESULTS: Fifty-five eyes of 39 patients with ocular inflammation temporally related to vaccination were identified. Twenty-two patients (36 eyes) were de novo , while 17 (19 eyes) were recurrent. Anterior uveitis was most common. HLA-B27 positivity was found in 6 (27.2%) de novo patients, and 5 (29.4%) recurrent patients. Most patients required only observation, topical, or systemic corticosteroids. Among vaccinated patients, 12.3% of new uveitis referrals during the study period were related to coronavirus disease 2019 vaccination. Among patients with a history of quiescent uveitis, only 0.85% experienced a flare after vaccination. CONCLUSION: Most inflammation thought to be secondary to coronavirus disease 2019 vaccination achieved quiescence with observation or steroids, and the overall incidence is low. Anterior uveitis was the most common. HLA-B27 positivity occurred at a higher rate than reported in the baseline population.
引用
- Arepalli S, Kopplin L, Tsui E, et al. THE HETEROGENEOUS PRESENTATIONS OF DE NOVO AND RECURRENT OCULAR INFLAMMATION AFTER COVID-19 VACCINATION : A Multicenter Report and a Review of the Literature. Retina. 2025. PMID: 39841907. doi:10.1097/IAE.0000000000004413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。